Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,460 | 4 | 64.3% |
| Food and Beverage | $4,140 | 217 | 28.1% |
| Travel and Lodging | $1,015 | 4 | 6.9% |
| Education | $95.81 | 4 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $0.72 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $8,783 | 34 | $0 (2023) |
| Celgene Corporation | $2,995 | 46 | $0 (2019) |
| ABBVIE INC. | $487.01 | 27 | $0 (2024) |
| Amgen Inc. | $449.70 | 21 | $0 (2023) |
| Galderma Laboratories, L.P. | $333.52 | 21 | $0 (2022) |
| Janssen Biotech, Inc. | $320.11 | 18 | $0 (2024) |
| Biofrontera Inc. | $206.19 | 5 | $0 (2018) |
| GENZYME CORPORATION | $205.20 | 9 | $0 (2024) |
| Genentech USA, Inc. | $117.07 | 5 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $103.19 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $260.05 | 11 | Janssen Biotech, Inc. ($73.13) |
| 2023 | $659.34 | 31 | Amgen Inc. ($183.29) |
| 2022 | $499.80 | 28 | ABBVIE INC. ($262.10) |
| 2021 | $205.39 | 9 | PFIZER INC. ($71.75) |
| 2019 | $1,895 | 38 | Celgene Corporation ($1,384) |
| 2018 | $2,051 | 51 | Celgene Corporation ($1,503) |
| 2017 | $9,140 | 62 | PFIZER INC. ($8,386) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $40.22 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Immunology | ||||||
| 04/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Immunology | ||||||
| 03/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Biosimilars | ||||||
| 01/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Immunology | ||||||
| 11/29/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Dermatology | ||||||
| 11/21/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Inflammation | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Podiatry | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology | ||||||
| 10/25/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.26 | General |
| 08/29/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Inflammation | ||||||
| 08/29/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Inflammation | ||||||
| 08/08/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 07/25/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: Immunology | ||||||
| 06/26/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 5,957 | 14,997 | $1.8M | $758,567 |
| 2022 | 40 | 6,509 | 16,688 | $2.0M | $882,731 |
| 2021 | 41 | 6,182 | 17,506 | $1.7M | $809,968 |
| 2020 | 36 | 4,930 | 11,917 | $1.2M | $553,808 |
All Medicare Procedures & Services
154 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 881 | 1,454 | $180,296 | $91,537 | 50.8% |
| 17108 | Destruction of birthmark, more than 50.0 sq cm | Office | 2023 | 69 | 172 | $180,600 | $87,033 | 48.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 85 | 276 | $138,000 | $84,609 | 61.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 815 | 1,124 | $281,000 | $82,550 | 29.4% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 85 | 257 | $93,548 | $59,584 | 63.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 264 | 423 | $105,750 | $40,104 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 375 | 412 | $79,516 | $36,868 | 46.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 652 | 1,035 | $142,830 | $35,809 | 25.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 555 | 6,410 | $128,200 | $35,622 | 27.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 599 | 934 | $76,588 | $27,426 | 35.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 224 | 517 | $47,564 | $22,442 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $34,580 | $14,888 | 43.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 65 | 82 | $26,076 | $13,120 | 50.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 124 | 133 | $23,674 | $11,647 | 49.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 73 | 91 | $23,842 | $11,635 | 48.8% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 38 | 69 | $22,632 | $11,238 | 49.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 69 | 79 | $21,646 | $10,721 | 49.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 87 | 93 | $20,088 | $10,442 | 52.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 137 | 137 | $25,756 | $9,965 | 38.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 68 | 72 | $25,200 | $9,210 | 36.5% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 43 | 48 | $13,680 | $6,935 | 50.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 53 | 59 | $12,390 | $6,427 | 51.9% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 61 | 63 | $12,978 | $6,117 | 47.1% |
| 24075 | Removal of growth under skin of upper arm or elbow, less than 3.0 cm | Office | 2023 | 11 | 13 | $11,700 | $5,769 | 49.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 51 | 61 | $11,224 | $5,457 | 48.6% |
About Dr. Stuart Jacobs, MD
Dr. Stuart Jacobs, MD is a Dermatology healthcare provider based in Stockton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073574539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Jacobs, MD has received a total of $14,711 in payments from pharmaceutical and medical device companies, with $260.05 received in 2024. These payments were reported across 230 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($9,460).
As a Medicare-enrolled provider, Jacobs has provided services to 23,578 Medicare beneficiaries, totaling 61,108 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 154 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Stockton, CA
- Active Since 03/31/2006
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073574539
Products in Payments
- EUCRISA (Drug) $8,712
- Otezla (Drug) $2,929
- RINVOQ (Biological) $221.88
- Enbrel (Biological) $200.18
- DUPIXENT (Biological) $166.46
- AMELUZ (Drug) $142.66
- HUMIRA (Biological) $123.00
- TREMFYA (Drug) $122.00
- Erivedge (Biological) $117.07
- Tremfya (Drug) $108.47
- Sotyktu (Drug) $94.92
- SKYRIZI (Biological) $85.87
- CIBINQO (Drug) $70.93
- Santyl (Drug) $67.60
- Ameluz (Drug) $63.53
- Humira (Biological) $56.26
- STELARA (Biological) $50.89
- OPZELURA (Drug) $46.23
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $40.63
- DERMATITIS - DISEASE (Drug) $38.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Stockton
Gerald Bock, Md, MD
Dermatology — Payments: $2,322
Walter Yourchek, Md, MD
Dermatology — Payments: $1,819
Kyle Herbold, M.d, M.D
Dermatology — Payments: $1,745
Dr. Christy Behnam, Md, MD
Dermatology — Payments: $1,443
Lydia Kim, M.d, M.D
Dermatology — Payments: $1,404
Karen Bissell, Md, MD
Dermatology — Payments: $766.31